Plasma oxalate and glycolate levels in patients with chronic kidney disease (CKD stage 4 and 5).

Plasma oxalate and glycolate levels in patients with chronic kidney disease (CKD stage 4 and 5). - POx study

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

NL-OMON

Registry ID

NL-OMON52424

Enrollment

150

Registered

2020-03-12

Start date

2020-06-22

Completion date

Unknown

Last updated

2024-04-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hyperoxaluria Oxalosis

Interventions

None listed

Eligibility

Age

2 Years to 64 Years

Inclusion criteria

Inclusion criteria: Patients with estimated glomerular filtration rate

Exclusion criteria

Exclusion criteria: Patients who are unable to give informed consent.

Design outcomes

Primary

Measure	Time frame
Reference values for plasma oxalate levels in patients with ESRD.	—

Secondary

Measure	Time frame
Reference values for plasma glycolate levels in patients with ESRD.	—

Countries

Netherlands

Outcome results